GCIS
GlobalChemical Inventory Search
Levodopa
L-3,4-二羟苯丙氨酸
,
L-3-(3,4-二羟苯基)苯胺
,
左旋多
,
3.4-二羟基-L-苯丙氨酸
,
L-多巴
,
L-多巴
,
左多巴
,
左多巴
,
3-羟基-L-酪氨酸
,
3,4-二羟基-L-苯基丙氨酸
,
3-(3,4-二羟基苯基)-L-丙氨酸
,
L-3-(3,5-二羟苯基)苯胺, (-)-dopa, L-3,4-Dihydroxyphenylalanine, l-dop, Dopar, Alanine, 3- (3,4-dihydroxyphenyl)-, L-, 3,4-Dihydroxy-L-phenylalanine, Doprin, L-4,5-Dihydroxyphenylalanine, Parda, Doparl, Tyrosine, 3-hydroxy-, Beldopa, EINECS 200-445-2, 3-Hydroxytyrosine, Levopa, Bendopa, (−)-dopa, L-DOPA, MFCD00002598, L-3-(3,4-dihydroxyphenyl)-Alanine, Levodopa, Ledopa
CAS Number: 59-92-7
IUPAC name: (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
Molecular formula: C9H11NO4
Molecular weight: 197.188
InChI: InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1
InChIKey: WTDRDQBEARUVNC-LURJTMIESA-N
SMILES: C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O
EINECS: -
One-Click Alert
Regions
Filter All
Category
Filter All
Sort
By key inventories
By listed

Focused on chemical complianceEmpowering the entire lifecycle of the chemical industry
Substance Information
CAS Number:
59-92-7
Chemical Name:
Levodopa
Chinese name:
3-羟基-L-酪氨酸
Date of inquiry :
Apr 23, 2026
Inquiry website:
https://www.chemradar.com/en/tools/gcisGCIS inquiry report
| Inventory Name | Country/Region | Status | Obligations |
|---|
ChemRadar
Global chemical compliance information, data and technical service platform
Service Hotline: +353 1 477 3710 (EU) +86 571 8720 6598 (CN) +81 70 9365 8022 (JP) +82 2 6347 8816 (KR)
Disclaimer
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.
